Characterization of the muscarinic receptor mediating contraction of the dog prostate

Journal of Autonomic Pharmacology

Volumn 18, Issue 4, 1998, Pages 205-212

  Fernandez J L G ^a   Rivera, L ^a   Lopez P G ^a   Recio, P ^a   Vela Navarrete, R ^b   Garcia Sacristan A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALPHA ADRENERGIC RECEPTOR; ATROPINE; BETA ADRENERGIC RECEPTOR; BETHANECHOL; CARBACHOL; HEXAMETHONIUM; HIMBACINE; METHOCTRAMINE; MUSCARINIC M3 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR; OTENZEPAD; OXOTREMORINE M; PHENTOLAMINE; PIRENZEPINE; PROPRANOLOL; RECEPTOR SUBTYPE; TROPICAMIDE; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOG; MALE; NONHUMAN; PROSTATE; SMOOTH MUSCLE CONTRACTION;

EID: 0031708734     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2680.1998.18486.x     Document Type: Article

References (39)

1. BARTSCH, G., BRUENGGER, A., DE KLERCK, D.P., COFFEY, D.S. & ROHR, P. (1987). Light-microscopic stereologic analysis of spontaneous and steroid-induced canine prostatic hyperplasia. Br. J. Urol., 137, 552-558.
2. BOREHAM, P.F., BRAITHWAITE, P., MILEWSKI, P. & PEARSON, H. (1977). Alpha-adrenergic blockers in prostatism. Br. J. Surg., 64, 756-765.
3. BRESLIN, D., FIELDS, D.W., CHOU, T.C., MARION, D.N., KANE, M., VAUGHAN JR, E.D. & FELSEN, D. (1993). Medical management of benign prostatic hyperplasia: a canine model comparing the in vivo efficacy of alpha-1 adrenergic antagonist in the prostate. J. Urol., 149, 395-399.
4. CAINE, M., PERLBERG, S. & MERETYK, S. (1978). A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction. Br. J. Urol., 50, 551-556.
5. CAINE, M., RAZ, S. & ZIGLER, M. (1975). Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Br. J. Urol., 47, 193-202.
6. CAULDFIELD, M.P. (1993). Muscarinic receptors-characterization, coupling and function. Pharmacol. Ther., 58, 319-379.
7. DAIL, W.G. (1993). Autonomic innervation of male reproductive genitalia. In: Nervous Control of the Urogenital System, The Autonomic Nervous System, Vol. 3, pp. 69-101 (ed. C.A. Maggi). Harwood, Switzerland.
8. EGLEN, R.M., REDDY, H., WATSON, N. & CHALLISS, R.A.J. (1994). Muscarinic acetylcholine receptor subtypes in smooth muscle. Trends Pharmacol. Sci., 151, 114-119.
9. EGLEN, R.M. & WATSON, N. (1996). Selective muscarinic receptor agonists and antagonists. Pharmacol. Toxicol., 78, 59-68.
10. GARCÍA-SACRISTÁN, A., CASANUEVA, C.R., CASTILLA, C. & LABADIA, A. (1984). Adrenergic receptors in the urethra and prostate of the horse. Res. Vet. Sci., 36, 57-60.
11. GERSTENBERG, T., BLAABJERG, J., NIELSEN, M.L. & CLAUSEN, S. (1983). Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia. A urodinamic investigation. Invest. Urol., 18, 29-37.
12. GOSLING, J.A. (1983). Autonomic innervation of the prostate. In: Benign Prostatic Hypertrophy, Ch. 32, pp. 349-360 (ed. F. Hinman Jr). Springer-Verlag, New York.
13. GOSLING, J.A. & THOMPSON, S.A. (1977). A neurohistochemical and histological study of peripheral autonomic neurons of human bladder neck and prostate. Invest. Urol., 130, 275-381.
14. GUP, D., SHAPIRO, M., BAUMANN, M. & LEPOR, H. (1990). Autonomic receptors in human prostate adenomas. J. Urol., 143, 179-183.
15. HEDLUND, H., ANDERSSON, K.E. & EK, A. (1983). Effects of prazoxin in patients with benign prostatic obstruction. J. Urol., 130, 275-282.
16. HEDLUND, H., ANDERSSON, K.E. & LARSSON, B. (1985). Alpha-adrenoceptors and muscarinic receptors in the isolated human prostate. J. Urol., 134, 1291-1299.
17. HERNÁNDEZ, M., SIMONSEN, U., PRIETO, D., RIVERA, L., GARCIA, P., ORDAZ, E. & GARCÍA-SACRISTÁN, A. (1993). Different muscarinic receptor subtypes mediating the phasic activity and basal tone of pig isolated intravesical ureter. Br. J. Pharmacol., 110, 1413-1420.
18. HIEBLE, J.P., BOYCE, A.J. & CAINE, M. (1986). Comparison of the alfa-adrenoceptor characteristics in human and canine prostate. Federation Proc., 45, 2609-2614.
19. JAMES, S., CHAPPLE, C.R., PHILLIPS, M.I., GREENGRASS, P.M., DAVEY, M.J., TURNER-WARWICK, R.T., MILROY, E.J.G. & BURNSTOCK, G. (1989). Autoradiographic analysis of alpha-adrenoceptors and muscarinic cholinergic receptors in the hyperplastic human prostate. J. Urol., 142, 438-443.
20. KATO, T., WATANABE, H., SHIMA, M. & KAIHO, H. (1971). Studies on the innervation of prostate. 2. Histological changes of the dog prostate after transsection of its innervating nerves. Jpn. J. Urol., 62, 704-711.
21. LEFF, P. & DOUGALL, I.G. (1993). Further concerns over Cheng-Prusoff analysis. Trends Pharmacol. Sci., 14, 88-92.
22. LEPOR, H. & KUHAR, M.J. (1984). Characterization and localization of the muscarinic cholinergic receptor in human prostatic tissue. J. Urol., 132, 397-402.
23. LEPOR, H., AUERBACH, S., PURAS-BAEZ, A., NARAYAN, P., SOLOWAY, M., LOWE, F., MOON, T., LEIFER, G. & MADSEN, P.A. (1992). Randomized placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. J. Urol., 148, 1467-1474.
24. OWMAN, C. & SJOSTRAND, N.O. (1965). Short adrenergic neurons and catecholamine-containing cells in vas deferens and accessory male genital glands of different mammals. Zeit. Zell. Forsch., 66, 300-319.
25. POYET, P., GOGNE, B., LAVAIE, M. & LABRIE, F. (1986). Characterization of the beta-adrenergic receptor in rat ventral prostate using (125I) cyanopindolol. Mol. Cell. Endocrinol., 48, 59-65.
26. RAYFORD, W., SHAH, G.V. & NOBLE, M.J. (1994). Muscarinic receptors may act as agonist dependent oncogenes in human prostate cancer. J. Urol., 134, 490A.
27. RAZ, S., ZIGLER, M. & CAINE, M. (1973). Pharmacological receptors in the prostate. Br. J. Urol., 45, 663-667.
28. RUGGIERI, M.R., COLTON, M.D., WANG, P., WANG, J., SMYTH, R.J., PONTARI, M.A. & LUTHIN, G.R. (1995). Human prostate muscarinic receptor subtypes. J. Pharmacol. Exp. Ther., 274, 976-982.
29. SHAPIRO, E., TSITLIK, J.E. & LEPOR, H. (1987). Alpha2 adrenergic receptors in canine prostate: bichemical and functional correlations. J. Urol., 137, 565-570.
30. SKARBY, T.V. & LARSSON, B. (1987). Theoretical and functional studies on alpha1 and alpha2-adrenoceptors: and examination using the Schild plot. J. Autonom. Pharmacol., 7, 185-198.
31. VAALASTI, A. & HERVONEN, A. (1980). Autonomic innervation of the human prostate. Invest. Urol., 17, 293-299.
32. WADDELL, J.A. (1917). The pharmacology of the prostate. J. Pharmacol., 9, 179-189.
33. WALLESTEIN, S., ZUCKER, G.L. & FLEISS, J.L. (1980). Some statistical methods useful in circulation research. Circ. Res., 47, 1-9.
34. WALSH, P.C. & WILSON, J.D. (1976). The induction of prostatic hypertrophy in the dog with androstendiol. J. Clin. Invest., 57, 1093-1099.
35. WATANABE, H. (1968). Tissue respiration of the partially denervated dog prostate. Tohoku J. Exp. Med., 95, 193-201.
36. WATANABE, H., SHIMA, M., KOJIMA, M. & OHE, H. (1988). Dynamic study of nervous control on prostatic contraction and fluid excretion in the dog. J. Urol., 140, 1567-1570.
37. YAMADA, S., ASHIZAWA, N., USHIJIMA, H., NAKAYAMA, K., HAYASHI, E. & HONDA, K. (1987). Alpha-1 adrenoceptors in human prostate: characterization and alteration in benign prostatic hypertrophy. J. Pharmacol. Exp. Ther., 242, 326-331.
38. YAMADA, S., TANAKA, C., KIMURA, R. & KAWABE, K. (1994). Alpha-1 adrenoceptors in human prostate: characterization and binding characteristics of alpha-1 antagonist. Life Sci., 54, 1845-1854.
39. YAZAWA, H., SAITA, Y., IIDA, E., HONMA, Y., MORITA, T. & HONDA, K. (1994). Characterization of muscarinic cholinoceptor in primary culture of smooth muscle cells from human prostate. J. Urol., 152, 2173-2177.